Sally C. Medley

Array ( [id] => 3617593 [patent_doc_number] => 05593667 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Recombinant immune interferon having an intact carboxyl terminus' [patent_app_type] => 1 [patent_app_number] => 8/359356 [patent_app_country] => US [patent_app_date] => 1994-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 7760 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593667.pdf [firstpage_image] =>[orig_patent_app_number] => 359356 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648000 [patent_doc_number] => 05629291 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-05-13 [patent_title] => 'Methods of modulating fibronectin extracellular matrix assembly' [patent_app_type] => 1 [patent_app_number] => 8/340812 [patent_app_country] => US [patent_app_date] => 1994-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 38 [patent_no_of_words] => 15893 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/629/05629291.pdf [firstpage_image] =>[orig_patent_app_number] => 340812 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3662917 [patent_doc_number] => 05648465 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Cloning and expression of neurocan, a chondroitin sulfate proteoglycan' [patent_app_type] => 1 [patent_app_number] => 8/340428 [patent_app_country] => US [patent_app_date] => 1994-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 24547 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648465.pdf [firstpage_image] =>[orig_patent_app_number] => 340428 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3884729 [patent_doc_number] => 05723329 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-03 [patent_title] => 'DNA encoding retinoid receptor X (RXR) alpha and gamma; corresponding vectors and host cells' [patent_app_type] => 1 [patent_app_number] => 8/336408 [patent_app_country] => US [patent_app_date] => 1994-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7910 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 128 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/723/05723329.pdf [firstpage_image] =>[orig_patent_app_number] => 336408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3790908 [patent_doc_number] => 05726035 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Recombinant production of mammalian calcium channel gamma subunits' [patent_app_type] => 1 [patent_app_number] => 8/336257 [patent_app_country] => US [patent_app_date] => 1994-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 53 [patent_no_of_words] => 12879 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726035.pdf [firstpage_image] =>[orig_patent_app_number] => 336257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3728300 [patent_doc_number] => 05700913 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-23 [patent_title] => 'Unglycosylated human interleukin-2 polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/331146 [patent_app_country] => US [patent_app_date] => 1994-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8315 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/700/05700913.pdf [firstpage_image] =>[orig_patent_app_number] => 331146 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989247 [patent_doc_number] => 05891664 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)' [patent_app_type] => 1 [patent_app_number] => 8/319052 [patent_app_country] => US [patent_app_date] => 1994-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 53 [patent_figures_cnt] => 83 [patent_no_of_words] => 62620 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 166 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891664.pdf [firstpage_image] =>[orig_patent_app_number] => 319052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549154 [patent_doc_number] => 05547854 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-08-20 [patent_title] => 'DNA encoding a receptor for Mullerian inhibitory substance, misr1, and corresponding vectors, cells, probes, and recombinant methods' [patent_app_type] => 1 [patent_app_number] => 8/317847 [patent_app_country] => US [patent_app_date] => 1994-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 23 [patent_no_of_words] => 11632 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/547/05547854.pdf [firstpage_image] =>[orig_patent_app_number] => 317847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3620551 [patent_doc_number] => 05593862 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-01-14 [patent_title] => 'Nucleic acids encoding drosophila tipE cation channel proteins and recombinant expression of the same' [patent_app_type] => 1 [patent_app_number] => 8/317880 [patent_app_country] => US [patent_app_date] => 1994-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 21 [patent_no_of_words] => 16191 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/593/05593862.pdf [firstpage_image] =>[orig_patent_app_number] => 317880 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3535138 [patent_doc_number] => 05556944 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-09-17 [patent_title] => 'Immunoglobulin a binding protein' [patent_app_type] => 1 [patent_app_number] => 8/330515 [patent_app_country] => US [patent_app_date] => 1994-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3121 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/556/05556944.pdf [firstpage_image] =>[orig_patent_app_number] => 330515 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3625596 [patent_doc_number] => 05686241 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-11 [patent_title] => 'Probes and assays for calcium channel .alpha..sub.2 subunit-encoding nucleic acids' [patent_app_type] => 1 [patent_app_number] => 8/314083 [patent_app_country] => US [patent_app_date] => 1994-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 10536 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/686/05686241.pdf [firstpage_image] =>[orig_patent_app_number] => 314083 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3924460 [patent_doc_number] => 05876958 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Assays of cells expressing human calcium channels containing .alpha..sub.1 .beta. subunits' [patent_app_type] => 1 [patent_app_number] => 8/311363 [patent_app_country] => US [patent_app_date] => 1994-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 23 [patent_no_of_words] => 29780 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 218 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/876/05876958.pdf [firstpage_image] =>[orig_patent_app_number] => 311363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4221153 [patent_doc_number] => 06010872 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-04 [patent_title] => 'Recombinant production of TGF-.beta. type III receptor (betaglycan) polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/311703 [patent_app_country] => US [patent_app_date] => 1994-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 3 [patent_no_of_words] => 14974 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/010/06010872.pdf [firstpage_image] =>[orig_patent_app_number] => 311703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3811870 [patent_doc_number] => 05789187 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'Identification of differentiation factor receptors which inhibit the tumorigenicity of neuroblastoma cells in a ligand-independent manner' [patent_app_type] => 1 [patent_app_number] => 8/310287 [patent_app_country] => US [patent_app_date] => 1994-09-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 21 [patent_no_of_words] => 6644 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789187.pdf [firstpage_image] =>[orig_patent_app_number] => 310287 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3960337 [patent_doc_number] => 05885567 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-23 [patent_title] => 'Treatment of infection in fowl by oral administration of avian interferon proteins' [patent_app_type] => 1 [patent_app_number] => 8/308821 [patent_app_country] => US [patent_app_date] => 1994-09-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7584 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/885/05885567.pdf [firstpage_image] =>[orig_patent_app_number] => 308821 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3799672 [patent_doc_number] => 05830456 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Treatment of viral disease with oral interferon-.alpha.' [patent_app_type] => 1 [patent_app_number] => 8/305418 [patent_app_country] => US [patent_app_date] => 1994-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7099 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830456.pdf [firstpage_image] =>[orig_patent_app_number] => 305418 [rel_patent_id] =>[rel_patent_doc_number] =>)